US FDA approves Takeda, Protagonist's drug for rare blood cancer - Reuters
US FDA approves Takeda, Protagonist's drug for rare blood cancer Reuters
Coverage by Political Leaning
See how different sides of the spectrum reported this story
Key People
No people linked to this story
Locations
All Coverage
<a href="https://news.google.com/rss/articles/CBMisAFBVV95cUxQS1REZ1lsNjRDTXlLYkt6T3F3bEdFcFA1UDRKdEJGX05aTFk1OE9wNjRLVHZncE1LQzg1S01PMG5kOEx5dEJoQUJHbVBmT1NDSG16NjJ2dEpFLU9TNmlWVENST0d6M2NaTnUxei1KYm9aWm9Wc0VSempseUxtd1BfN2xCZTBvdHdBYy1FT2Rzczg5X21ZTFhIT0llaDZwajRWZFFtdXdOS2pybjNzSk5oWA?oc=5" target="_blank">US FDA approves Takeda, Protagonist's drug for rare blood cancer</a> <font color="#6f6f6f">Reuters</font>
Similar Stories
Related coverage based on topic and tags
US FDA approves AbbVie's drug for Parkinson's disease - reuters.com
US FDA approves AbbVie's drug for Parkinson's disease reuters.com
September 25, 2026 at 10:57 PMUS FDA advisers endorse Grail cancer test's benefits in key vote - Reuters
US FDA advisers endorse Grail cancer test's benefits in key vote Reuters
September 23, 2026 at 11:03 PMUS FDA approves Mirum's drug for rare bone disorder - reuters.com
US FDA approves Mirum's drug for rare bone disorder reuters.com
September 25, 2026 at 08:11 PMCancer patient told she will get drug which could make her life longer
Patients in England with an incurable breast cancer can now access a life-extending drug on the NHS, two years after it was deemed too expensive by a health body.
September 17, 2026 at 05:28 AMMerck's drug for diabetes-related eye disease meets trial goal - Reuters
Merck's drug for diabetes-related eye disease meets trial goal Reuters
September 24, 2026 at 02:52 PMNew hope for breast cancer patients as life-extending drug now on NHS in England
Enhertu, which can give patients an extra seven months to live on average, has been prescribed in Scotland for more than two years and is available.
September 16, 2026 at 11:50 PM